DEFA14A: CERO Therapeutics Postpones Special Stockholder Meeting to September 19

CERO Therapeutics Holdings, Inc. announced the postponement of its special meeting of stockholders from September 12, 2024, to September 19, 2024.

Summary

• CERO Therapeutics Holdings, Inc. has postponed its special meeting of stockholders.
• The meeting was originally scheduled for September 12, 2024, at 12:00 p.m. Eastern Time.
• The new date and time for the Special Meeting is September 19, 2024, at 10:00 a.m. Eastern Time.
• The meeting will still be held virtually at www.cstproxy.com/cero/2024.
• The record date for the Special Meeting remains August 26, 2024.
• Stockholders who have already submitted their proxies do not need to take any action if they do not wish to change their vote.
• Stockholders as of the record date can vote, even if they have subsequently sold their shares.
• Stockholders who wish to change their vote can contact Advantage Proxy, Inc. for assistance at 1-877-870-8565 or ksmith@advantageproxy.com.

Sentiment

Score: 5

Explanation: The document is a neutral announcement about a change in meeting schedule. It doesn't contain any overtly positive or negative information.

Risks

• The document contains forward-looking statements that are subject to risks and uncertainties.
• These risks and uncertainties include outcomes of planned clinical trials and studies, regulatory approval, and intellectual property protection.
• The company's Annual Report on Form 10-K, filed on April 2, 2024, contains a more detailed description of these risks.

Future Outlook

The document contains forward-looking statements regarding the date, time, and place of the postponed Special Meeting, but cautions that these statements are subject to risks and uncertainties.

Industry Context

This announcement is a routine update regarding corporate governance and shareholder meetings, which is common for publicly traded companies.

Stakeholder Impact

• Shareholders need to be aware of the change in date and time for the Special Meeting.
• Shareholders who have already voted do not need to take action unless they wish to change their vote.

Key Dates

Keywords

Special Meeting, Stockholders, Postponement, CERO Therapeutics, Proxy, Voting